Clinical trial
Tissue Expander/Implant Reconstruction: A Single-Blinded, Randomized, Controlled…
NCT00639106 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00639106 |
|---|---|
| Title | Tissue Expander/Implant Reconstruction: A Single-Blinded, Randomized, Controlled Trial |
| Official title | The Use of Alloderm in Two-Stage, Tissue Expander/Implant Reconstruction: A Single-Blinded, Randomized, Controlled Trial |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | University of Michigan University of North Carolina, Chapel Hill |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Procedure |
| Interventions | Alloderm, Questionnaires, Without ALLODERM |
| Enrollment | 70 |
| Start date | Mar 1, 2008 |
| Primary completion | Oct 1, 2018 |
| Completion | Oct 1, 2018 |
| First posted | Mar 19, 2008 |
| Last update posted | Oct 3, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: